- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Edwin J. Hassid, MD
He | Him | HisInternal Medicine- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Edwin J. Hassid, MD
He | Him | HisInternal Medicine- Accepting New Patients
- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Edwin J. Hassid is a specialist in internal medicine who provides primary care. To ensure he delivers comprehensive care, he is committed to giving each patient the time they need and to listening carefully.
Hassid earned his medical degree at UCSF, where he also completed a residency in internal medicine and a fellowship in infectious diseases.
Hassid is proud to have many patients for whom he has cared through multiple significant life events. He still has two patients who began seeing him in 1976, his first year of practice. Outside of work, he enjoys traveling and travel photography.
This provider works with UCSF through the UCSF Health Community Medical Group, a multispecialty group connecting doctors and practices throughout the Bay Area.
Education & training
Board certification
- Internal Medicine, American Board of Medical Specialties
Fellowship
- Infectious Diseases, UCSF Graduate Medical Education
Residency
- Internal Medicine, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, UCSF School of Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%22121%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22121%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.